Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.

MLA

Hayes, Andrew J., et al. “Wide versus Narrow Excision Margins for High-Risk, Primary Cutaneous Melanomas: Long-Term Follow-up of Survival in a Randomised Trial.” The Lancet. Oncology, vol. 17, no. 2, Feb. 2016, pp. 184–92. EBSCOhost, https://doi.org/10.1016/S1470-2045(15)00482-9.

APA

Hayes, A. J., Maynard, L., Coombes, G., Newton-Bishop, J., Timmons, M., Cook, M., Theaker, J., Bliss, J. M., & Thomas, J. M. (2016). Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial. The Lancet. Oncology, 17(2), 184–192. https://doi.org/10.1016/S1470-2045(15)00482-9

Chicago

Hayes, Andrew J, Lauren Maynard, Gillian Coombes, Julia Newton-Bishop, Michael Timmons, Martin Cook, Jeffrey Theaker, Judith M Bliss, and J Meirion Thomas. 2016. “Wide versus Narrow Excision Margins for High-Risk, Primary Cutaneous Melanomas: Long-Term Follow-up of Survival in a Randomised Trial.” The Lancet. Oncology 17 (2): 184–92. doi:10.1016/S1470-2045(15)00482-9.